ANKRD20A18P: A Potential Drug Target and Biomarker (G391269)

Target Name: ANKRD20A18P

NCBI ID: G391269

ANKRD20A18P

Other Name(s): Ankyrin repeat domain 20 family, member A18, pseudogene | ankyrin repeat domain 20 family member A18, pseudogene | C21orf126

ANKRD20A18P: A Potential Drug Target and Biomarker

Introduction

The Ankyrin repeat domain (ANKRD) is a conserved protein motif that has been identified in various organisms as being involved in various cellular processes. One of the ANKRD motifs is the ANKRD20A18P protein, which has been identified as a potential drug target and biomarker. In this article, we will provide an overview of ANKRD20A18P, its function, and potential as a drug target and biomarker.

Function of ANKRD20A18P

The ANKRD20A18P protein is a member of the ANKRD family and is located within the protein kinase CKL (Cullin-3) gene. ANKRD20A18P is a 20 kDa protein that contains an N-terminal ANKRD20A18P domain, a central 尾-sheet, and a C- terminal T-loop. The ANKRD20A18P domain is characterized by a specific conserved sequence, which includes a leucine-rich region, a conserved Asp-thr- Glu-Asp loop, and a conserved lysine-rich region.

The ANKRD20A18P protein is involved in various cellular processes, including cell signaling, DNA replication, and protein synthesis. It is a key regulator of the Ankyrin repeat gene (ANKRD), which is highly conserved across various species. The ANKRD20A18P protein is responsible for the maintenance of ANKRD protein levels in the cell and for the regulation of ANKRD-rich protein interactions.

Potential as a Drug Target

The ANKRD20A18P protein is a potential drug target due to its unique structure and its involvement in various cellular processes. The ANKRD20A18P protein has been shown to interact with various small molecules, including inhibitors of protein kinase CKL. Additionally, the ANKRD20A18P protein has been shown to play a role in the regulation of DNA replication and protein synthesis, which are crucial processes for cellular growth and survival.

The ANKRD20A18P protein can also be targeted by small molecules that specifically interact with the ANKRD20A18P protein. These small molecules can include inhibitors of protein synthesis, DNA replication, or protein kinase activity. By inhibiting these processes, the ANKRD20A18P protein can be degraded or inhibited, leading to a decrease in cellular activity and potential therapeutic benefits.

Potential as a Biomarker

The ANKRD20A18P protein is also a potential biomarker for various diseases. The ANKRD20A18P protein is highly conserved across various species, which suggests that it may be a useful biomarker for tracking disease progression. tissues, including brain, heart, and liver, which suggests that it may be a useful biomarker for tracking the effects of diseases on these tissues.

The ANKRD20A18P protein can also be used as a target for small molecules that specifically interact with the protein. By using these small molecules, researchers can study the effects of these molecules on the ANKRD20A18P protein and its function in various cellular processes. This can provide valuable information for the development of new therapeutic approaches for various diseases.

Conclusion

The ANKRD20A18P protein is a unique and conserved protein that is involved in various cellular processes. Its function as a regulator of the Ankyrin repeat gene and its potential as a drug target and biomarker make it an attractive target for further study. Further research is needed to fully understand the functions of the ANKRD20A18P protein and its potential as a therapeutic approach for various diseases.

Protein Name: Ankyrin Repeat Domain 20 Family Member A18, Pseudogene

The "ANKRD20A18P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANKRD20A18P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets